RCMI Coordinating Center (RCMI CC) Header Logo

Nitazoxanide May Modify the Course of Progressive Multifocal Leukoencephalopathy.

Hautala TJ, Perelygina L, Vuorinen T, Hautala NM, H?gg PM, Bode MK, Rusanen HT, Renko MH, Glumoff V, Schwab N, Schneider-Hohendorf T, Murk JL, Sullivan KE, Sepp?nen MRJ. Nitazoxanide May Modify the Course of Progressive Multifocal Leukoencephalopathy. J Clin Immunol. 2018 01; 38(1):4-6.

View in: PubMed

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support